IBIO, INC. (IBIO) - More strength today (21 Feb)?
@nerdbull1669:
$iBio(IBIO)$ is an innovator of precision antibody immunotherapies. This company have invested in AI, and their platform is AI-driven. The company is constantly investing in continued development of the RubrYc® Discovery Engine, the artificial intelligence (“AI”) platform used to create the majority of iBio’s therapeutic candidates. This is useful especially now A.I. hype is still on, here is one good example of how A.I. is being used in the biotechnology industry. Hence, we should look beyond what A.I. is actually all about. The focus have been on the search engine and ChatGPT. There are much more useful investment to be made into an A.I. driven company like $iBio(IBIO)$ 17 Feb 23 - Surge in share price